Influence of osteogenic stimulation and VEGF treatment on in vivo bone formation in hMSC-seeded cancellous bone scaffolds

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Lenze, Ulrich ^a,b   Pohlig, Florian ^a,b   Seitz, Sebastian ^c   Ern, Christina ^a   Milz, Stefan ^a   Docheva, Denitsa ^a   Schieker, Matthias ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

HMSC; Osteogenic stimulation; Tissue engineering; Vascularization; VEGF

Indexed keywords

GENOMIC DNA; VASCULOTROPIN; DNA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCELLOUS BONE SCAFFOLD; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; STEM CELL CULTURE; TISSUE SCAFFOLD; ANIMAL; BONE DEVELOPMENT; CELL COUNT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; NUDE MOUSE; PHYSIOLOGY; TISSUE ENGINEERING;

ANIMALS; CELL COUNT; CELLS, CULTURED; DNA; HUMANS; MESENCHYMAL STROMAL CELLS; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84932115283     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-350     Document Type: Article

References (25)

1. Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti JP, Langer R: Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 1993, 42:716-723.
2. Santos MI, Reis RL: Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010, 10:12-27.
3. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
4. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH: VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 2006, 21:735-744.
5. Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP: Evaluation of VEGFmediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 2008, 214:537-544.
6. Grellier M, Granja PL, Fricain JC, Bidarra SJ, Renard M, Bareille R, Bourget C, Amedee J, Barbosa MA: The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
7. Via AG, Frizziero A, Oliva F: Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J 2012, 2:154-162.
8. Seitz S, Ern K, Lamper G, Docheva D, Drosse I, Milz S, Mutschler W, Schieker M: Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng 2007, 13:1059-1067.
9. van Gaalen SM, Dhert WJ, van den Muysenberg A, Oner FC, Van Blitterswijk C, Verbout AJ, De Bruijn JD: Bone tissue engineering for spine fusion: an experimental study on ectopic and orthotopic implants in rats. Tissue Eng 2004, 10:231-239.
10. Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I: Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer 2002, 87:1328-1335.
11. Docheva D, Popov C, Mutschler W, Schieker M: Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med 2007, 11:21-38.
12. Mauney JR, Jaquiery C, Volloch V, Heberer M, Martin I, Kaplan DL: In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 2005, 26:3173-3185.
13. Bareille R, Lafage-Proust MH, Faucheux C, Laroche N, Wenz R, Dard M, Amedee J: Various evaluation techniques of newly formed bone in porous hydroxyapatite loaded with human bone marrow cells implanted in an extra-osseous site. Biomaterials 2000, 21:1345-1352.
14. Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y, Ohgushi H: In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 2009, 33:474-481.
15. Kruyt MC, de Bruijn JD, Wilson CE, Oner FC, van Blitterswijk CA, Verbout AJ, Dhert WJ: Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 2003, 9:327-336.
16. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H: Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 2007, 1:306-313.
17. Wang Y, Uemura T, Dong J, Kojima H, Tanaka J, Tateishi T: Application of perfusion culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng 2003, 9:1205-1214.
18. Zilkens C, Logters T, Bittersohl B, Krauspe R, Lensing-Hohn S, Jager M: Spinning around or stagnation-what do osteoblasts and chondroblasts really like? Eur J Med Res 2010, 15:35-43.
19. Delaine-Smith RM, Reilly GC: Mesenchymal stem cell responses to mechanical stimuli. Muscles Ligaments Tendons J 2012, 2:169-180.
20. Volkmer E, Drosse I, Otto S, Stangelmayer A, Stengele M, Kallukalam BC, Mutschler W, Schieker M: Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A 2008, 14:1331-1340.
21. Rouwkema J, Rivron NC, van Blitterswijk CA: Vascularization in tissue engineering. Trends Biotechnol 2008, 26:434-441.
22. Kruyt MC, Dhert WJ, Yuan H, Wilson CE, van Blitterswijk CA, Verbout AJ, de Bruijn JD: Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 2004, 22:544-551.
23. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H: Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 2007, 13:1325-1331.
24. Volkmer E, Kallukalam BC, Maertz J, Otto S, Drosse I, Polzer H, Bocker W, Stengele M, Docheva D, Mutschler W, Schieker M: Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A 2010, 16:153-164.
25. Chen L, He Z, Chen B, Yang M, Zhao Y, Sun W, Xiao Z, Zhang J, Dai J: Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. J Mater Sci Mater Med 2010, 21:309-317.